Which drugs have no barrier to distribution via tissue membranes and are solely perfusion limited?

Which drugs have no barrier to distribution via tissue membranes and are solely perfusion limited?

• A. Lipophilic drugs
• B. Hydrophilic drugs
• C. Very large peptide drugs
• D. Highly protein-bound drugs

Answer: (A)

Perfusion-limited distribution occurs when a drug can cross tissue membranes readily, so the speed of distribution between plasma and tissues is governed mainly by blood flow to the tissue rather than by membrane barriers. Lipophilic drugs cross cell membranes through the lipid bilayer with little hindrance, so they equilibrate quickly with tissues as blood flows through. That means their distribution is essentially limited by perfusion, not by any membrane barrier, making them the ones with no significant membrane barrier to distribution. Hydrophilic drugs, on the other hand, struggle to cross lipid membranes and rely more on diffusion through aqueous pathways or active transport, so their distribution is constrained by membrane permeability rather than by how much blood reaches a tissue. Very large peptide drugs are typically unable to cross membranes efficiently due to their size, so they face substantial barriers and their distribution is not perfusion-limited. Highly protein-bound drugs have a large fraction bound to plasma proteins, leaving only a small free portion to distribute into tissues; the distribution is limited by binding dynamics, not just tissue perfusion, so they don’t fit the perfusion-limited scenario.

Perfusion-limited distribution occurs when a drug can cross tissue membranes readily, so the speed of distribution between plasma and tissues is governed mainly by blood flow to the tissue rather than by membrane barriers.

Lipophilic drugs cross cell membranes through the lipid bilayer with little hindrance, so they equilibrate quickly with tissues as blood flows through. That means their distribution is essentially limited by perfusion, not by any membrane barrier, making them the ones with no significant membrane barrier to distribution.

Hydrophilic drugs, on the other hand, struggle to cross lipid membranes and rely more on diffusion through aqueous pathways or active transport, so their distribution is constrained by membrane permeability rather than by how much blood reaches a tissue.

Very large peptide drugs are typically unable to cross membranes efficiently due to their size, so they face substantial barriers and their distribution is not perfusion-limited.

Highly protein-bound drugs have a large fraction bound to plasma proteins, leaving only a small free portion to distribute into tissues; the distribution is limited by binding dynamics, not just tissue perfusion, so they don’t fit the perfusion-limited scenario.